V028-5091 Screening compound: 4-methoxy-N-{1-[1-(2-methoxyacetyl)piperidin-4-yl]-2-oxo-2-(piperidin-1-yl)ethyl}benzamide

V028-5091 Screening compound: 4-methoxy-N-{1-[1-(2-methoxyacetyl)piperidin-4-yl]-2-oxo-2-(piperidin-1-yl)ethyl}benzamide
V028-5091 Screening compound: 4-methoxy-N-{1-[1-(2-methoxyacetyl)piperidin-4-yl]-2-oxo-2-(piperidin-1-yl)ethyl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-5091
4-methoxy-N-{1-[1-(2-methoxyacetyl)piperidin-4-yl]-2-oxo-2-(piperidin-1-yl)ethyl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-5091

Molecular Formula

C23H33N3O5 (C23 H33 N3 O5)

Compound Name

4-methoxy-N-{1-[1-(2-methoxyacetyl)piperidin-4-yl]-2-oxo-2-(piperidin-1-yl)ethyl}benzamide

IUPAC name

4-methoxy-N-{1-[1-(2-methoxyacetyl)piperidin-4-yl]-2-oxo-2-(piperidin-1-yl)ethyl}benzamide

SMILES

COCC(N(CC1)CCC1C(C(N1CCCCC1)=O)NC(c(cc1)ccc1OC)=O)=O

InChI

InChI=1S/C23H33N3O5/c1-30-16-20(27)25-14-10-17(11-15-25)21(23(29)26-12-4-3-5-13-26)24-22(28)18-6-8-19(31-2)9-7-18/h6-9,17,21H,3-5,10-16H2,1-2H3,(H,24,28)/t21-/m0/s1

InChI Key

VFXQWMKAGPPAJP-NRFANRHFSA-N

MDL Number (MFCD)

MFCD19874578

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

431.53

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.224

Distribution Coefficient, logD

1.224

Water Solubility, LogSw

-1.92

Polar Surface Area

73.012

Acid Dissociation Constant (pKa)

11.54

Base Dissociation Constant (pKb)

3.72

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

60.90

V028-5091 in Drug Discovery

Included in Screening Libraries

Serine Proteases Inhibitors Library (32732 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with V028-5091 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-5091?
Check Price and Availability of V028-5091, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-5091 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-5091
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-5091
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-5091 available by request